Filtered By:
Management: National Institutes of Health (NIH)
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 769 results found since Jan 2013.
He battled AIDS, COVID-19, and Trump. Now, Anthony Fauci is stepping down
Anthony Fauci, the renowned physician-scientist who has led the $6.3 billion National Institute of Allergy and Infectious Diseases (NIAID) for nearly 4 decades and since early 2020 has been the U.S. government’s voice of scientific reason during the COVID-19 pandemic, will step down from government service in December.
Fauci, 81, had said in
recent interviews
that he planned to retire from the government by the end of President Joe Biden’s administration, but did not give a date until today. He said in a
statement
that although leading NIAID “has been the honor of a lifetime,” he plans to “pursue...
Source: Science of Aging Knowledge Environment - August 22, 2022 Category: Geriatrics Source Type: research
Dr. Anthony Fauci Is Stepping Down From His Public-Health Posts
Dr. Anthony Fauci, the nation’s leading infectious disease official, will step down from heading the National Institute of Allergy and Infectious Diseases (NIAID) in December, he said in a statement released on Aug. 22. Fauci, 81, said he would also leave his role as chief medical advisor to President Joe Biden.
But Fauci, who has served as NIAID director since 1984—under seven presidents—said he is not retiring. “I plan to pursue the next phase of my career while I still have so much energy and passion for my field,” he said.
Fauci first made his mark on public health through his work fightin...
Source: TIME: Health - August 22, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Fauci Says He Will Step Down in December to Pursue His ‘Next Chapter’
Dr. Anthony S. Fauci, who has advised seven presidents and spent more than half a century at the National Institutes of Health, will leave government service by the end of the year.
Source: NYT Health - August 22, 2022 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Fauci, Anthony S National Institute of Allergy and Infectious Diseases National Institutes of Health Appointments and Executive Changes Government Employees United States Politics and Government Coronavirus (2019-nCoV) Biden, Joseph R Jr T Source Type: news
What to Know About the Monkeypox Drug TPOXX —And Why It ’ s So Hard to Get
Monkeypox, which federal officials declared a public health emergency on August 4, is not as contagious as the other ongoing public health emergency in the U.S.: COVID-19. Monkeypox primarily spreads through contact with infected skin lesions. Theoretically, containing monkeypox should therefore be more feasible, as long as testing, vaccines, and treatments are accessible. But in reality, the rollouts of all three approaches have faced major challenges. Getting the antiviral drug tecovirimat, also known as TPOXX, is particularly difficult.
Here’s what to know about the antiviral drug treatment TPOXX.
What is TPOXX?
T...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
UCLA awarded $11.5 million to improve organ, hand and face transplantation
The Dumont –UCLA Transplant Center has received two grants totaling $11.5 million from the federal government for research aimed at making donated organs last longer and helping transplant recipients live longer, healthier lives.The grant projects — one funded by the National Institutes of Health and the other by the Department of Defense — focus specifically on improving outcomes in liver transplantation and in hand and face transplantation.Both initiatives are led by Dr. Jerzy Kupiec-Weglinski, UCLA ’s Paul I. Terasaki Professor of Surgery and vice chair of basic research in the surgery department at theDavid Gef...
Source: UCLA Newsroom: Health Sciences - July 29, 2022 Category: Universities & Medical Training Source Type: news
Vaccine-induced immune response to omicron wanes substantially over time
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data. The findings, published today in Cell Reports Medicine, are from a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial was led by NIAID's Infectious Diseases Clinical Research Consortium.
Source: World Pharma News - July 19, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
NIH Trial Underway for Universal Flu Vaccine
WEDNESDAY, July 13, 2022 -- The National Institutes of Health Clinical Center has begun a phase I trial of a potential universal influenza vaccine, according to an announcement by the agency.
The National Institute of Allergy and Infectious...
Source: Drugs.com - Pharma News - July 13, 2022 Category: Pharmaceuticals Source Type: news
NIH launches clinical trial of mRNA Nipah virus vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus. The experimental vaccine is manufactured by Moderna, Inc., (Cambridge, Massachusetts) and was developed in collaboration with NIAID's Vaccine Research Center. It is based on a messenger RNA (mRNA) platform - a technology used in several approved COVID-19 vaccines.
Source: World Pharma News - July 11, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Dr. Anthony Fauci Tests Positive for COVID-19 With Mild Symptoms
Dr. Anthony Fauci, the face of America’s pandemic response through two White House administrations, has tested positive for the coronavirus.
The 81-year-old Fauci, who is fully vaccinated and has received two booster shots, was experiencing mild COVID-19 symptoms, according to a statement Wednesday from the National Institutes of Health.
Fauci has not recently been in close contact with President Joe Biden or other senior government officials. He tested positive on a rapid antigen test. He is following public health guidelines and his doctor’s advice, and will return to work at the NIH when he tests negative, a...
Source: TIME: Health - June 15, 2022 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news
News at a glance: China ’s carbon pledge, ARPA-H’s interim head, and an exascale computer
Some content has been removed for formatting reasons. Please view the original article for the best reading experience.
Table of contents
A version of this story appeared in Science, Vol 376, Issue 6597.
Download PDF
CONSERVATION
U.S. moves to stop Alaska copper mine
The U.S. Environmental Protection Agency (EPA) is moving to block construction of a massive copper and gold mine that would risk polluting the headwaters of Alaska’s Bristol Bay, home to the world’s largest sockeye salmon runs. EPA announced last week it plans to forbid dis...
Source: Science of Aging Knowledge Environment - June 2, 2022 Category: Geriatrics Source Type: research
Food allergy is associated with lower risk of SARS-CoV-2 infection
NIH study finds high BMI and obesity raise infection risk, but asthma does not.
Source: National Institutes of Health (NIH) News Releases - June 1, 2022 Category: American Health Source Type: news
Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news
Tim Kaine Refuses to Let Long COVID Be an Afterthought
When Virginia Sen. Tim Kaine came down with a “blizzard” of allergy-like symptoms in March 2020, he blamed the layer of pollen coating his car. “It was Washington, D.C., in late March,” he says. I thought, “‘Okay, well, this is hay fever gone wild.’”
Only when his wife, Anne Holton, developed “textbook” COVID-19 symptoms did Kaine start to wonder if he might have the new virus, the subject of the massive economic assistance bill—the CARES Act—that he and other lawmakers were then working to pass. Testing at that time was hard to come by, even for Hill...
Source: TIME: Health - May 4, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 feature Source Type: news
Why Acupuncture Is Going Mainstream in Medicine
When the opioid addiction crisis began to surge in the U.S. about a decade ago, Dr. Medhat Mikhael spent a lot of time talking to his patients about other ways to heal pain besides opioids, from other types of medications to alternative treatments.
As a pain management specialist at MemorialCare Orange Coast Medical Center in Fountain Valley, Calif., he didn’t anticipate leaving behind the short-term use of opioids altogether, since they work so well for post-surgical pain. But he wanted to recommend a remedy that was safer and still effective.
That turned out to be acupuncture.
“Like any treatment, acupuncture...
Source: TIME: Health - April 29, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized healthscienceclimate medicine Source Type: news
Asthma, allergy risk may be higher for children conceived with infertility treatment
The study enrolled approximately 5,000 mothers and 6,000 children born between 2008 and 2010.
Source: National Institutes of Health (NIH) News Releases - April 21, 2022 Category: American Health Source Type: news
